scholarly article | Q13442814 |
P50 | author | Zuojiong Gong | Q61162460 |
P2093 | author name string | Hui Chen | |
Cheng Fan | |||
Xun Li | |||
Lu-Wen Wang | |||
Li-Kun Wang | |||
Can-Ming He | |||
P2860 | cites work | High mobility group box-1 protein inhibits regulatory T cell immune activity in liver failure in patients with chronic hepatitis B | Q64937350 |
Activation of gene expression in human neutrophils by high mobility group box 1 protein | Q73087842 | ||
Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis | Q73740629 | ||
Changes in intestinal microflora in patients with chronic severe hepatitis | Q77458775 | ||
Systemic endotoxemia during chronic viral hepatitis | Q78505626 | ||
Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis | Q79269759 | ||
Increased serum and hepatic tissue levels of interleukin-18 in patients with fulminant hepatic failure | Q80291576 | ||
The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury | Q80490374 | ||
Not just nuclear proteins: 'novel' autophagy cancer treatment targets - p53 and HMGB1 | Q82746541 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
Targeting HMGB1 in inflammation | Q28266138 | ||
RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages | Q28568915 | ||
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes | Q28574795 | ||
HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic | Q33799406 | ||
Novel HMGB1-inhibiting therapeutic agents for experimental sepsis | Q33814903 | ||
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation | Q34156078 | ||
Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution | Q34530931 | ||
The pathophysiological basis of acute-on-chronic liver failure | Q34830328 | ||
Intestinal endotoxemia as a pathogenetic mechanism in liver failure | Q35002596 | ||
Ringer's ethyl pyruvate solution: a novel resuscitation fluid for the treatment of hemorrhagic shock and sepsis | Q35136460 | ||
Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. | Q35856595 | ||
Acute liver failure: a critical appraisal of available animal models | Q36355365 | ||
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion | Q36403403 | ||
Influence of heme oxygenase-1 expression on immune liver fibrosis induced by cobalt protoporphyrin in rats | Q37241948 | ||
Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury | Q39797512 | ||
HMGB1 develops enhanced proinflammatory activity by binding to cytokines. | Q40016396 | ||
Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). | Q40230859 | ||
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells | Q40686939 | ||
Ethyl pyruvate modulates acute inflammatory reactions in human endothelial cells in relation to the NF-kappaB pathway | Q40884597 | ||
Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model. | Q42062324 | ||
A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha | Q43709297 | ||
Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats | Q44031120 | ||
Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury | Q44902660 | ||
Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia | Q45020202 | ||
Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis | Q45235016 | ||
Ethyl pyruvate prevents intestinal inflammatory response and oxidative stress in a rat model of extrahepatic cholestasis. | Q45921694 | ||
Effect of ethyl pyruvate on physical and immunological barriers of the small intestine in a rat model of sepsis. | Q46017280 | ||
Ethyl pyruvate protects colonic anastomosis from ischemia-reperfusion injury | Q46209458 | ||
Ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis | Q46232195 | ||
PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia | Q46421830 | ||
Post-synthetic acetylation of HMGB1 protein modulates its interactions with supercoiled DNA. | Q46452162 | ||
Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats | Q46595796 | ||
Ethyl pyruvate ameliorates ileus induced by bowel manipulation in mice | Q46743207 | ||
A critical role in structure-specific DNA binding for the acetylatable lysine residues in HMGB1. | Q46778200 | ||
Establishment of a D-galactosamine/lipopolysaccharide induced acute-on-chronic liver failure model in rats | Q46929281 | ||
Effect of treatment with ethyl pyruvate on multiple organ dysfunction and mortality following delayed resuscitation after burn injury in rat | Q46980846 | ||
Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis | Q46981742 | ||
P433 | issue | 40 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liver failure | Q970208 |
P304 | page(s) | 5709-5718 | |
P577 | publication date | 2012-10-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats | |
P478 | volume | 18 |
Q42266454 | Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. |
Q28068263 | Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries |
Q41909868 | Ethyl pyruvate pretreatment attenuates concanavalin a-induced autoimmune hepatitis in mice. |
Q42268031 | Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure |
Q36621514 | Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats |
Q39037784 | Inhibitions of NF-κB and TNF-α result in differential effects in rats with acute on chronic liver failure induced by d-Gal and LPS. |
Q35843059 | Liuweiwuling tablets attenuate acetaminophen-induced acute liver injury and promote liver regeneration in mice |
Q36815008 | Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats |
Q42210945 | Sodium butyrate protects against toxin-induced acute liver failure in rats. |
Q47095662 | The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC). |
Q38212568 | The brain in acute on chronic liver failure |
Q41532442 | Trichostatin A Protects Against Experimental Acute-on-Chronic Liver Failure in Rats Through Regulating the Acetylation of Nuclear Factor-κB. |